DOI QR코드

DOI QR Code

췌장암 조기진단을 위한 조건부 확률 기반 지능형 진단 방식

Intelligent Diagnosing Method Based on the Conditional Probability for the Pancreatic Cancer Early Detection

  • 장익규 (구미전자정보기술원 전자의료기술연구본부) ;
  • 정준호 (구미전자정보기술원 전자의료기술연구본부) ;
  • 고재호 (메디엇주식회사) ;
  • 문현석 (금오공과대학교 응용화학과) ;
  • 조영호 (국립암센터의공학과)
  • JANG, IK GYU (Gumi Electronics & Information Technology Research Institute Electronic Medical Technology Research Division Convergence Medical Devices Research Center) ;
  • JUNG, JOONHO (Gumi Electronics & Information Technology Research Institute Electronic Medical Technology Research Division Convergence Medical Devices Research Center) ;
  • KO, JAE HO (MeDIoT CO., LTD.) ;
  • MOON, HYUN SEOK (Department of Applied Chemistry, Kumoh National Institute of Technology) ;
  • JO, YUNG HO (National Cancer CenterDepartment of Biomedical Engineering)
  • 투고 : 2017.07.06
  • 심사 : 2017.10.11
  • 발행 : 2017.10.31

초록

Early diagnosis of pancreatic cancer had been considered one of the important barrier for successful therapy since the five year survival rate after treatment of pancreatic cancer was critically low. Nonetheless, patients often miss the golden time of treatment because they rarely visit the hospital until their symptoms are severe. To overcome these problems, a lot of information about the patient's symptoms should be applied as biomarkers for early diagnosis. For this reason, a biomarker for early detection of pancreatic cancer (CA19-9) has been developed as a diagnostic kit. However, since the diagnosis is not accurate enough, pancreatic symptoms (abdominal pain, jaundice, anorexia, diabetes, etc.) and biomarkers (CA19-9) should be considered together. We develop an intelligent diagnostic system that considers CA19-9 and the incidence of pancreatic cancer for pancreatic symptoms that was determined by studying a large number of patient information. It shows a higher accuracy than one using CA19-9 alone. It may increase the survival rate of pancreatic cancer because it can diagnose pancreatic cancer early.

키워드

참고문헌

  1. A.K. Sarnecka, M. Zagozda, M. Durlik, "An Overview of Genetic Changes and Risk of Pancreatic Ductal Adenocarcinoma", Journal of Cancer, vol. 7, no. 14, pp. 2045-2051, 2016. https://doi.org/10.7150/jca.15323
  2. M. Wahutu, K. Sara et al., "Pancreatic Cancer: A Survival Analysis Study in Oklahoma", Journal of Oklahoma State Medical Association, vol. 109, no. 7-8, pp. 391-398, 2016.
  3. S. Ngamruengphong, M. I. Canto, "Screening for Pancreatic Cancer", Surgical clinics of North America, vol. 96, pp. 1223-1233, 2016. https://doi.org/10.1016/j.suc.2016.07.016
  4. A.Mohamed, Y.Saad et al., "Can Serum ICAM1 distinguish pancreatic cancer from chronic pancreatitis", Asian Pacific Journal of Cancer Prevention, vol. 17, no. 10. pp. 4671-4675. https://doi.org/10.22034/APJCP.2016.17.10.4671
  5. G. Ge, G.W. Wong, "Classification of premalignant pancreatic cancer mass-spectrometry data using decision tree ensembles", BMC Bioinformatics, vol. 9, pp. 275, 2008. https://doi.org/10.1186/1471-2105-9-275
  6. F. Gorunescu, M. Grunescu et al., "Competitive collaborative neural computing system for medical diagnosis in pancreatic cancer detection", Biological Journal of the Linnean Society, vol. 28, no. 1, pp. 33, 2011.
  7. F.T. Dombal, D.J. Leaper et al., "Computer-aided diagnosis of acute abdominal pain", British Medical Joural, vol. 2, pp. 9-13, 1972.
  8. A. Alvaro-Meca, R. Gil-Prieto, Gil de Miguel A., "In-Hospital Death Caused by Pancreatic Cancer in Spain: Applicatioin with Bayesian Network", International Journal of Biomedical Science, vol. 7, no. 2, pp. 125-130, 2011.
  9. L. You, J. Xiao et al., "Analysis of clinical characteristics and treatment of pancreatic cystic tumors", Chinese Journal of Cancer Research, vol. 28, no. 5, pp. 519-527, 2016. https://doi.org/10.21147/j.issn.1000-9604.2016.05.07
  10. A. Engebretson, L. Matrisian, C. Thompson, "Patient and caregiver awareness of pancreatic cancer treatments and clinical trials", Journal of Gastrointestinal Oncology, vol. 7, no. 2, pp. 228-233, 2015.